Pharmacy alerts
-
Bumetanide 1mg tablets, update on shortage
National Patient Safety Alert: The MHRA has published on its National Patient Safety Alert on the shortage of Bumetanide 1mg tablets.
-
Bumetanide 1mg tablets shortage
National Patient Safety Alert: The MHRA has published a National Patient Safety Alert on the shortage of bumetanide 1mg tablets.
-
UK Government restrictions on the use of Puberty Suppressing Hormones (Puberty Blockers) additional information for prescribers and pharmacists/dispensing doctors. Scotland
The Chief Medical Officer (CMO) and the Chief Pharmaceutical Officer (CPhO) for Scotland has issued a letter with additional information on the restrictions on use of puberty supressing hormones. This includes: Information on the NHS research study Summary of the restriction changes Buying GnRH analogues from unregulated sources Guidance on working with unregulated providers Support for children and young people affected by this change and Prescribing scenarios for prescribers and dispensers. The information can be found in the CMO’s letter. Details Date 3 Jul 2025
-
Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell): updated safety and educational materials
Drug safety update: The MHRA has published a drug safety update on Valproate products with updated safety and educational materials to support patient discussion on reproductive risks.
-
Promixin® (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials to be discontinued
National Patient Safety Alert: The MHRA has published a National Patient Safety Alert that Promixin (colistimethate) 1-million unit powder for nebuliser solution unit dose vials are to be discontinued.
-
Prolonged-release opioids: indication for relief of post-operative pain removed
Drug safety update: The MHRA has published a drug safety update on prolonged-release opioids.